An inflammation-targeting hydrogel for local drug delivery in inflammatory bowel disease
There is a clinical need for new, more effective treatments for chronic and debilitating inflammatory bowel disease (IBD), including Crohn’s disease and ulcerative colitis. Targeting drugs selectively to the inflamed intestine may improve therapeutic outcomes and minimize systemic toxicity. We repor...
Main Authors: | Ermann, J., Zhou, A., Hamilton, M. J., Cao, B., Korzenik, J. R., Glickman, J. N., Vemula, P. K., Glimcher, L. H., Zhang, Sufeng, Succi, Marc David, Traverso, Carlo Giovanni, Langer, Robert S, Karp, Jeffrey Michael |
---|---|
Other Authors: | Harvard University--MIT Division of Health Sciences and Technology |
Format: | Article |
Language: | en_US |
Published: |
American Association for the Advancement of Science (AAAS)
2017
|
Online Access: | http://hdl.handle.net/1721.1/109405 https://orcid.org/0000-0002-9481-2258 https://orcid.org/0000-0002-4260-2785 https://orcid.org/0000-0003-4255-0492 |
Similar Items
-
Nanoparticulate drug delivery systems targeting inflammation for treatment of inflammatory bowel disease
by: Zhang, Sufeng, et al.
Published: (2022) -
Nanoparticulate drug delivery systems targeting inflammation for treatment of inflammatory bowel disease
by: Zhang, Sufeng, et al.
Published: (2021) -
Enzyme responsive acetaminophen hydrogels
by: Vemula, Praveen, et al.
Published: (2012) -
Microbial therapeutics: New opportunities for drug delivery
by: Jimenez, Miguel, et al.
Published: (2020) -
Controlled Delivery of Bile Acids to the Colon
by: Steiger, Christoph, et al.
Published: (2021)